Composition for the treatment of infections caused by Helicobacter
- 专利权人:
- ユニバーシダード デ ザラゴザ
- 发明人:
- サンチョ，サンツ，ジャビエール,ベラツクエツ キャムポイ，エイドリアン,クレマデス カサシン，ヌニロ,サンチョ,サンツ,ジャビエール,ベラツクエツ キャムポイ,エイドリアン,クレマデス カサシン,ヌニロ
- 申请号：
- JP2009551230
- 公开号：
- JP5478264B2
- 申请日:
- 2008.02.22
- 申请国别(地区):
- JP
- 年份:
- 2014
- 代理人:
- 摘要：
- The invention relates to a compound of general formula (I) for use in a pharmaceutical composition for treating infectious diseases caused by Helicobacter pylori. R 1 and R 2 are O, S or N, and can be identical or different； R 3 is O or S； R 4 is H or a (C 1 -C 6 ) alkyl group； n represents a value between 0 and 3； and R 5 is an NO 2 , COOR' or S o 3R' radical wherein R' is a hydrogen (H) atom or a (C 1 -C 6 ) alkyl group.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- NEW COMPOUND ISOLATED FROM PSEUDOLYSIMACHION ROTUNDUM VAR. SUBINTEGRUM, WITH A HIGH CONTENT OF ACTIVE INGREDIENT, COMPOSITION CONTAINING SAID COMPOUND FOR PREVENTING OR TREATING ALLERGIC DISEASE, INFLAMMATORY DISEASE, ASTHMA OR CHRONIC OBSTRUCTIVE PULMONARY DISEASE AND USE THEREOF
- A NOVEL COMPOUND ISOLATED FROM THE EXTRACT OF PSEUDOLYSIMACHION ROTUNDUM VAR. SUBINTEGRUM AND THE COMPOSITION COMPRISING THE SAME AS AN ACTIVE INGREDIENT FOR PREVENTING OR TREATING ALLERGY DISEASE, INFLAMMATORY DISEASE, ASTHMA OR CHRONIC OBSTRUCTIVE PULMONARY DISEASE
- Combination of hmg-coa reductase inhibitors with phosphodiesterase 4 inhibitors for the treatment of inflammatory pulmonary diseases
- VMAT2 INHIBITORS FOR THE TREATMENT OF NEUROLOGICAL DISEASES OR DISORDERS
- KS 513 a novel compound KS 513 isolated from the extract of Pseudolysimachion rotundum var. subintegrum and the composition comprising the same as an active ingredient for preventing or treating allergy disease inflammatory disease asthma or chronic obstructive pulmonary disease
